Extracellular Matrix Proteomics: The mdx-4cv Mouse Diaphragm as a Surrogate for Studying Myofibrosis in Dystrophinopathy
Biomolecules · 12.07.2023 · 13 (7) · 1108
DOI: 10.3390/biom13071108 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 12.07.2023. Verfasst von Paul Dowling und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Maynooth University, National University of Ireland, W23 F2H6 Maynooth, Co. Kildare, Ireland. Hauptthemen laut MEDLINE: Diaphragm, Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 317 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Science Foundation Ireland.
Abstract (Originalsprache)
The progressive degeneration of the skeletal musculature in Duchenne muscular dystrophy is accompanied by reactive myofibrosis, fat substitution, and chronic inflammation. Fibrotic changes and reduced tissue elasticity correlate with the loss in motor function in this X-chromosomal disorder. Thus, although dystrophinopathies are due to primary abnormalities in the DMD gene causing the almost-complete absence of the cytoskeletal Dp427-M isoform of dystrophin in voluntary muscles, the excessive accumulation of extracellular matrix proteins presents a key histopathological hallmark of muscular dystrophy. Animal model research has been instrumental in the characterization of dystrophic muscles and has contributed to a better understanding of the complex pathogenesis of dystrophinopathies, the discovery of new disease biomarkers, and the testing of novel therapeutic strategies. In this article, we review how mass-spectrometry-based proteomics can be used to study changes in key components of the endomysium, perimysium, and epimysium, such as collagens, proteoglycans, matricellular proteins, and adhesion receptors. The mdx-4cv mouse diaphragm displays severe myofibrosis, making it an ideal model system for large-scale surveys of systematic alterations in the matrisome of dystrophic fibers. Novel biomarkers of myofibrosis can now be tested for their appropriateness in the preclinical and clinical setting as diagnostic, pharmacodynamic, prognostic, and/or therapeutic monitoring indicators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Maynooth University, National University of Ireland, W23 F2H6 Maynooth, Co. Kildare, Ireland.
- Kathleen Lonsdale Institute for Human Health Research, Maynooth University, National University of Ireland, W23 F2H6 Maynooth, Co. Kildare, Ireland.
- Department of Neonatology and Paediatric Intensive Care, Children's Hospital, German Center for Neurodegenerative Diseases, University of Bonn, D53127 Bonn, Germany.
- Institute of Physiology, Medical Faculty, University of Bonn, D53115 Bonn, Germany.
ORCID-Profile: Dieter Swandulla, Kay Ohlendieck
Förderung
- Kathleen Lonsdale Institute for Human Health Research, Maynooth University
- Science Foundation Ireland
Zitieren
APA
Dowling, P., Gargan, S., Zweyer, M., Swandulla, D., & Ohlendieck, K. (2023). Extracellular Matrix Proteomics: The mdx-4cv Mouse Diaphragm as a Surrogate for Studying Myofibrosis in Dystrophinopathy. Biomolecules, 13(7), 1108. https://doi.org/10.3390/biom13071108
Vancouver
Dowling P, Gargan S, Zweyer M, Swandulla D, Ohlendieck K. Extracellular Matrix Proteomics: The mdx-4cv Mouse Diaphragm as a Surrogate for Studying Myofibrosis in Dystrophinopathy. Biomolecules. 2023;13(7):1108. doi:10.3390/biom13071108
BibTeX
@article{Dowling2023,
author = {Dowling, Paul and Gargan, Stephen and Zweyer, Margit and Swandulla, Dieter and Ohlendieck, Kay},
title = {Extracellular Matrix Proteomics: The mdx-4cv Mouse Diaphragm as a Surrogate for Studying Myofibrosis in Dystrophinopathy},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {7},
pages = {1108},
doi = {10.3390/biom13071108}
}
EUVIMED